Product Images Gabapentin

This is a chart showing the dosing schedule of Gabapentin, a medication used to treat certain types of seizures and nerve pain. The schedule involves a 4 week period of adjusting the dose followed by a 4 week period of fixed dosage. The chart also includes a placebo control. The headings show the baseline and subsequent weeks.*

The text shows a chart displaying pain scores over a period of 7 weeks. The chart depicts the results of a clinical trial that had a 3-week dose titration period, followed by a 4-week fixed dose period with either a placebo or gabapentin at 1800 mg/day or gabapentin at 2400 mg/day. The chart shows that the gabapentin groups had significant pain reduction compared to placebo. "p<0.01" indicates the statistical significance of these findings. However, no information is available about the condition being treated or the population studied.*

The text indicates the percentage of responders at an endpoint for a study 2, which included a treatment with GBP 1800 and GBP 2400. There are also some statistical significance levels shown with p<0.01 and p<0001. However, the information is not complete enough to provide a more detailed description.*

This is a pharmaceutical label for the drug Gabapentin 600mg, with NDC number 63187-006-90. It contains information such as the product identification number, dosage, quantity, and manufacturer location. The tablets are light green, capsule-shaped, film-coated, and imprinted with "LOGO" and 636 on one side, with a bisect on the other side. The label also includes directions for dispensing the medication guide to each patient and the storage conditions.*